SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Koninklijke DSM N.V. (RDSMY) 当前追踪市盈率 (P/E) 为 31.1. 追踪盈利收益率为 3.22%. PEG 0.63 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (60/100, 通过) — PEG ≤ 1.0 — Peter Lynch 低估标准 (0.63).
- PEG 比率 0.63 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 追踪盈利收益率 3.22% — 与债券收益率（约4.3%）大致持平，风险回报适中。
SharesGrow 综合评分： 68/100 其中 4/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
60/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — RDSMY
估值倍数
P/E (TTM)31.1
前瞻 P/EN/A
PEG 比率0.63
前瞻 PEGN/A
P/B 比率0.00
P/S 比率2.52
EV/EBITDA0.0
每股数据
EPS (TTM)$1.09
每股账面价值$0.00
每股营收$13.41
每股自由现金流$0.00
收益率与内在价值
盈利收益率3.22%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2012 |
$0.43 |
$9.13B |
$288M |
3.2% |
| 2013 |
$0.39 |
$9.05B |
$271M |
3% |
| 2014 |
$0.21 |
$9.18B |
$145M |
1.6% |
| 2015 |
$0.13 |
$7.72B |
$88M |
1.1% |
| 2016 |
$0.88 |
$7.92B |
$621M |
7.8% |
| 2017 |
$2.52 |
$8.63B |
$1.77B |
20.5% |
| 2018 |
$1.53 |
$9.27B |
$1.08B |
11.6% |
| 2019 |
$1.07 |
$9.01B |
$758M |
8.4% |
| 2020 |
$0.73 |
$8.11B |
$506M |
6.2% |
| 2021 |
$1.09 |
$9.2B |
$747M |
8.1% |
